Insider · CIK 0001849458
Tanguler Tolga
officerdirector
Files at ALNY (ALNYLAM PHARMACEUTICALS, INC.), LXEO (Lexeo Therapeutics, Inc.). First filing Nov 27, 2024, latest Mar 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $607k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 40Moderate | sell 5 | ALNY ALNYLAM PHARMACEUTICALS, INC. | $115k | 471 | -2% | +5% from low · -19% from high | |
| 25Weak | sell 5 | ALNY ALNYLAM PHARMACEUTICALS, INC. | $124k | 513 | -3% | +6% from low · -18% from high | |
| 50Moderate | sell 5 | ALNY ALNYLAM PHARMACEUTICALS, INC. | $369k | 1,469 | -10% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Common Stock | +14,137 | $0.00 | $0 | 28,482 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -131 | $242.37 | $32k | 28,351 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -142 | $243.36 | $35k | 28,209 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -96 | $244.41 | $23k | 28,113 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -70 | $245.26 | $17k | 28,043 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -29 | $246.18 | $7,139 | 28,014 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -3 | $247.35 | $742 | 28,011 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Stock Option (right to buy)derivative | +7,819 | $0.00 | $0 | 7,819 | Mar 5, 2025 |
| Feb 27, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +1,667 | $0.00 | $0 | 14,858 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -28 | $236.51 | $6,622 | 14,830 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -22 | $238.33 | $5,243 | 14,808 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -23 | $239.18 | $5,501 | 14,785 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -50 | $240.32 | $12k | 14,735 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -82 | $241.51 | $20k | 14,653 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -192 | $242.44 | $47k | 14,461 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -78 | $243.23 | $19k | 14,383 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -38 | $244.11 | $9,276 | 14,345 | Mar 3, 2025 |
| Feb 27, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -1,667 | $0.00 | $0 | 1,666 | Mar 3, 2025 |
| Nov 25, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Common Stock | +3,000 | $0.00 | $0 | 14,660 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -26 | $247.77 | $6,442 | 14,634 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -215 | $249.60 | $54k | 14,419 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -318 | $250.68 | $80k | 14,101 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -826 | $251.42 | $208k | 13,275 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -84 | $252.27 | $21k | 13,191 | Nov 27, 2024 |
| Nov 11, 2024 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +36,000 | $0.00 | $0 | 36,000 | Nov 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.